Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,340 warrant series at 1,059 companies. 779 in the money, 58 expiring in the next 30 days, 39 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| September 2024 pre-funded warrants (first tranche) | $0.2151 | $7.1M | 10-K, Feb 27, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Series A-1 Ordinary Share Purchase Warrants (February 2026 inducement) | $0.3401 | $7.1M | 424B5, Jun 11, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Series B-1 Ordinary Share Purchase Warrants (February 2026 inducement) | $0.3401 | $7.1M | 424B5, Jun 11, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| December 2021 registered-direct offering common stock warrants ($40.5155) | $1.08 | $7.1M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Common (SPO) Warrants (June 2023) | $0.7720 | $7.0M | 10-K, Mar 25, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Listed (IPO) Warrants (LUCYW) | $0.7720 | $7.0M | 10-K, Mar 25, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Placement Agent Warrants (April 2025 inducement, HCW, $3.25) | $0.7720 | $7.0M | S-1, Jul 23, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Placement Agent Warrants (April/May 2024 registered direct, HCW, $6.10) | $0.7720 | $7.0M | S-1, Jul 23, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Placement Agent Warrants (July 2026 inducement, HCW) | $0.7720 | $7.0M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Placement Agent Warrants (June 2023 offering, Maxim) | $0.7720 | $7.0M | S-1, Jul 23, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Placement Agent Warrants (June 2025 inducement, HCW, $3.25) | $0.7720 | $7.0M | S-1, Jul 23, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Placement Agent Warrants (May 2024 registered direct, HCW, $11.876) | $0.7720 | $7.0M | S-1, Jul 23, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Placement Agent Warrants (Sept 19, 2024 inducement, HCW, $6.4125) | $0.7720 | $7.0M | S-1, Jul 23, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Placement Agent Warrants (Sept 24, 2024 inducement, HCW, $12.3438) | $0.7720 | $7.0M | S-1, Jul 23, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Placement Agent Warrants (Sept 4, 2024 inducement, HCW, $6.25) | $0.7720 | $7.0M | S-1, Jul 23, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Private Warrants (April 2023 inducement) | $0.7720 | $7.0M | 10-K, Mar 25, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Representative's Warrants (IPO, Maxim) | $0.7720 | $7.0M | S-1, Jul 23, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series A Warrants (Sept 2024) | $0.7720 | $7.0M | 10-K, Mar 25, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series C Warrants (Sept 2024) | $0.7720 | $7.0M | 10-K, Mar 25, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series E Warrants (Sept 2024) | $0.7720 | $7.0M | 10-K, Mar 25, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series G Warrants (April 2025) | $0.7720 | $7.0M | S-1, Jul 23, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series I Warrants (June 2025) | $0.7720 | $7.0M | S-1, Jul 23, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series J Warrants (July 2026 inducement) | $0.7720 | $7.0M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Tail financing PA Warrants ($3.25) | $0.7720 | $7.0M | S-1, Jul 23, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Tail financing PA Warrants ($6.10) | $0.7720 | $7.0M | S-1, Jul 23, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Tail financing PA Warrants ($6.25) - remaining | $0.7720 | $7.0M | S-1, Jul 23, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Legacy warrants outstanding at December 31, 2024 (not itemised by series) | $1.66 | $7.0M | 10-K, Mar 31, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Mast Hill Fund, L.P. Common Stock Purchase Warrant (May 19, 2025, as amended June 2025) | $1.66 | $7.0M | 10-K, Mar 31, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| February 2026 Common Warrants - first tranche | $1.63 | $6.9M | 424B3, Oct 23, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| February 2026 Common Warrants - second tranche (Esousa holding) | $1.63 | $6.9M | PRE 14A, Oct 29, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| February 2026 Placement Agent Warrants (Dawson James) | $1.63 | $6.9M | 10-Q, Aug 18, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| February 2026 Pre-Funded Warrants (in lieu of Series B conversion shares) | $1.63 | $6.9M | 424B3, Oct 23, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Public and Private Warrants (DFNSW) | $1.63 | $6.9M | 10-Q, Aug 18, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| September 2025 Private Placement Warrant | $1.63 | $6.9M | 10-Q, Aug 18, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Star Warrant | $1.63 | $6.9M | 10-Q, Aug 18, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| 2025 Q3 SPA Warrants ($0.35, July 29, 2025) | $0.2255 | $6.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| 2025 Q4 Exchange Agreement Warrant ($0.35, October 21, 2025) | $0.2255 | $6.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| 2025 Q4 SPA Warrants ($0.35, November 20, 2025) | $0.2255 | $6.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| 2025 Q4 Subscription Agreement Warrants ($0.35, October 21, 2025) | $0.2255 | $6.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Alpha Eagle Sales Representative Warrant ($0.35, November 14, 2025) | $0.2255 | $6.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| December 8, 2023 Note Warrant (200,000 shares) | $0.2255 | $6.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Lucido Warrants $2.00 expiring November 9, 2027 (7,500) | $0.2255 | $6.9M | 10-K, Mar 31, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| USWM Asset Purchase Warrant No. 2025-001 ($1.00) | $0.2255 | $6.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| RCS/TIG Holdings LLC Warrant (issued with $2,000,000 subordinated promissory note, July 22, 2026) | $1.03 | $6.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2025 Lind Warrant | $0.1887 | $6.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2026 Lind Warrant | $0.1887 | $6.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| August 2025 Warrants (registered direct) | $0.1887 | $6.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Closing Underwriter Warrants (October 2025, Newbridge) | $0.1887 | $6.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Form A Warrants (December 2024 registered direct) | $0.1887 | $6.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Form B Warrants (December 2024 registered direct) | $0.1887 | $6.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 |
LIQTLiqTech International, Inc.$0.2151Last price
September 2024 pre-funded warrants (first tranche)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.1M
EVGNEVOGENE LTD.$0.3401Last price
Series A-1 Ordinary Share Purchase Warrants (February 2026 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.1M
EVGNEVOGENE LTD.$0.3401Last price
Series B-1 Ordinary Share Purchase Warrants (February 2026 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.1M
XCURExicure, Inc.$1.08Last price
December 2021 registered-direct offering common stock warrants ($40.5155)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.1M
LUCYLucyd, Inc$0.7720Last price
Common (SPO) Warrants (June 2023)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Listed (IPO) Warrants (LUCYW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Placement Agent Warrants (April 2025 inducement, HCW, $3.25)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Placement Agent Warrants (April/May 2024 registered direct, HCW, $6.10)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Placement Agent Warrants (July 2026 inducement, HCW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Placement Agent Warrants (June 2023 offering, Maxim)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Placement Agent Warrants (June 2025 inducement, HCW, $3.25)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Placement Agent Warrants (May 2024 registered direct, HCW, $11.876)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Placement Agent Warrants (Sept 19, 2024 inducement, HCW, $6.4125)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Placement Agent Warrants (Sept 24, 2024 inducement, HCW, $12.3438)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Placement Agent Warrants (Sept 4, 2024 inducement, HCW, $6.25)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Private Warrants (April 2023 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Representative's Warrants (IPO, Maxim)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Series A Warrants (Sept 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Series C Warrants (Sept 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Series E Warrants (Sept 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Series G Warrants (April 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Series I Warrants (June 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Series J Warrants (July 2026 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Tail financing PA Warrants ($3.25)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Tail financing PA Warrants ($6.10)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
LUCYLucyd, Inc$0.7720Last price
Tail financing PA Warrants ($6.25) - remaining
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
TCRTAlaunos Therapeutics, Inc.$1.66Last price
Legacy warrants outstanding at December 31, 2024 (not itemised by series)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
TCRTAlaunos Therapeutics, Inc.$1.66Last price
Mast Hill Fund, L.P. Common Stock Purchase Warrant (May 19, 2025, as amended June 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$7.0M
DFNST3 Defense Inc.$1.63Last price
February 2026 Common Warrants - first tranche
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.9M
DFNST3 Defense Inc.$1.63Last price
February 2026 Common Warrants - second tranche (Esousa holding)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.9M
DFNST3 Defense Inc.$1.63Last price
February 2026 Placement Agent Warrants (Dawson James)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.9M
DFNST3 Defense Inc.$1.63Last price
February 2026 Pre-Funded Warrants (in lieu of Series B conversion shares)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.9M
DFNST3 Defense Inc.$1.63Last price
Public and Private Warrants (DFNSW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.9M
DFNST3 Defense Inc.$1.63Last price
September 2025 Private Placement Warrant
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.9M
DFNST3 Defense Inc.$1.63Last price
Star Warrant
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.9M
BICXBioCorRx Inc.$0.2255Last price
2025 Q3 SPA Warrants ($0.35, July 29, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.9M
BICXBioCorRx Inc.$0.2255Last price
2025 Q4 Exchange Agreement Warrant ($0.35, October 21, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.9M
BICXBioCorRx Inc.$0.2255Last price
2025 Q4 SPA Warrants ($0.35, November 20, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.9M
BICXBioCorRx Inc.$0.2255Last price
2025 Q4 Subscription Agreement Warrants ($0.35, October 21, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.9M
BICXBioCorRx Inc.$0.2255Last price
Alpha Eagle Sales Representative Warrant ($0.35, November 14, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.9M
BICXBioCorRx Inc.$0.2255Last price
December 8, 2023 Note Warrant (200,000 shares)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.9M
BICXBioCorRx Inc.$0.2255Last price
Lucido Warrants $2.00 expiring November 9, 2027 (7,500)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.9M
BICXBioCorRx Inc.$0.2255Last price
USWM Asset Purchase Warrant No. 2025-001 ($1.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.9M
AMSAmerican Shared Hospital Services$1.03Last price
RCS/TIG Holdings LLC Warrant (issued with $2,000,000 subordinated promissory note, July 22, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.9M
VNRXVolitionRX Ltd$0.1887Last price
2025 Lind Warrant
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
VNRXVolitionRX Ltd$0.1887Last price
2026 Lind Warrant
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
VNRXVolitionRX Ltd$0.1887Last price
August 2025 Warrants (registered direct)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
VNRXVolitionRX Ltd$0.1887Last price
Closing Underwriter Warrants (October 2025, Newbridge)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
VNRXVolitionRX Ltd$0.1887Last price
Form A Warrants (December 2024 registered direct)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
VNRXVolitionRX Ltd$0.1887Last price
Form B Warrants (December 2024 registered direct)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$6.8M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,075 dilution snapshots. 4,886 of 5,340 series state an exercise price and 3,371 an expiry date. 223 record when exercise begins; that count grows as companies are re-extracted. 625 series are left off because their figures could not be restated for a stock split. 19 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.